BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 4,650.00
+110.00 (2.42%)
At close: May 13, 2025, 3:30 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 471.33 billion as of May 13, 2025. Its market cap has increased by 14.03% in one year.
Market Cap
471.33B
Enterprise Value
69.84B
Revenue
102.78B
Ranking
n/a
PE Ratio
8.58
Stock Price
4,650.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 471.33B, a decrease of -56.56%. That is a compound annual growth rate of -29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 460.18B | -4.27% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 33.69T |
| ALTEOGEN | 18.39T |
| Yuhan | 8,026.78B |
| HLB Co., Ltd. | 7,581.42B |
| SK Biopharmaceuticals | 7,079.52B |
| PharmaResearch | 4,171.44B |
| Peptron | 3,872.02B |